Comparison of Two Methods of Continuous Positive Airway Pressure (CPAP) to Support Successful Extubation of Infants of Birth Weights ≤ 1500 Grams (C2CPAP)
|ClinicalTrials.gov Identifier: NCT00187434|
Recruitment Status : Unknown
Verified September 2005 by Sunnybrook Health Sciences Centre.
Recruitment status was: Recruiting
First Posted : September 16, 2005
Last Update Posted : January 23, 2007
|Condition or disease||Intervention/treatment|
|Premature Birth Respiratory Insufficiency||Device: Infant Flow System Device: Bubble CPAP|
Background: Continuous Positive Airway Pressure (CPAP) has been used successfully to promote extubation in the premature infant population (Davis & Henderson-Smart, 2002). The two methods of CPAP to be examined are used by many institutions, yet no study has compared these methods to determine which is better in the population of newborns < 1500 grams (birth weight) at supporting extubation. This study may have cost savings implications. If bubble CPAP is shown to be as effective in this application neonatal intensive care units (NICUs) will have a more affordable option of providing effective CPAP.
Methods: This randomised controlled, single site, clinical study is to determine if Bubble CPAP or Infant Flow System (IFS) CPAP is more effective at supporting extubation in infants of birth weights < 1500 grams. Seventy-six infants will be randomised immediately prior to extubation to IFS or Bubble CPAP of 5 cmH2O. The primary outcome is successful extubation, defined as not reaching failure criteria for the 7 days post-extubation. Failure criteria are defined as pH < 7.25 and PCO2 > 65 mmHg or a sustained increase in FiO2 of 0.15.
Participants: Parents/guardians of eligible infants will be approached and given information regarding the study, and any questions answered. They will then be allowed to consider study participation in private. The recruiter will return at an agreed time and informed consent will be obtained from those agreeing to participate. Parents will be approached in accordance with the guidelines of the NICU @ SWCHSC. Infants are eligible if birth weight < 1500 grams, are to be extubated to CPAP and have no known airway anomalies, or suspected genetic anomalies.
Analysis: Multiple ANOVA analysis will be used for continuous variables, chi-square for categorical variables, including primary outcome.
Conclusion: The results of this study will determine which method of CPAP is the best method of supporting extubation in the < 1500 g infant.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||76 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Randomized Control Trial Comparing Two Methods of Delivering Continuous Positive Airway Pressure (CPAP), Infant Flow System CPAP and Bubble CPAP, in Supporting Successful Extubation of Infants of Birth Weights Less Than or Equal to 1500 Grams at Birth (C2CPAP)|
|Study Start Date :||September 2003|
- failure of extubation as defined by the following: pH < 7.25 and PCO2 > 65 (or an increase of 15 mmHg from pre-extubation), a sustained (> 1 hour) increase in FiO2 of .15 (as compared to pre-extubation) or significant apno
- length of time in days on CPAP
- corrected gestational age at cessation of CPAP
- average weight gain on CPAP
- assessment of pain will
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00187434
|Contact: Marilyn D Hyndman||416 323 6400 ext email@example.com|
|Sunnybrook & Women's College Health Sciences Centre||Recruiting|
|Toronto, Ontario, Canada, M4L 2Y6|
|Contact: Marilyn D Hyndman 416 323 6400 ext 4172 firstname.lastname@example.org|
|Principal Investigator: Marilyn D Hyndman|
|Principal Investigator:||Marilyn D Hyndman||Sunnybrook & Women's College Health Sciences Centre|